Managers / Q1 2025 · view latest →
FORMULA GROWTH LTD
CIK 0001093219 · 1010 SHERBROOKE ST W SUITE 2300, MONTREAL, A8, H3A 2R7 · 514-288-5136
Summary
Formula Growth Ltd reported $247M in U.S.-listed holdings across 118 positions for Q1 2025.
Its largest position, SWIM, represents 3.0% of the portfolio.
Compared with Q4 2024, the fund opened 28 new positions and exited 25.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 88.0% · $217M
- Other · 9.9% · $25M
- ADR · 2.1% · $5M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TEAM1EURATLASSIAN CORPORATION | NEW | +24.5K | 24.5K | +$5M | $5M |
| TTDTHE TRADE DESK INC | NEW | +91.0K | 91.0K | +$5M | $5M |
| RHRH | NEW | +15.1K | 15.1K | +$4M | $4M |
| PHRPHREESIA INC | NEW | +111.3K | 111.3K | +$3M | $3M |
| HQYHEALTHEQUITY INC | NEW | +30.0K | 30.0K | +$3M | $3M |
| UTHUNITED THERAPEUTICS CORP DEL | NEW | +8.4K | 8.4K | +$3M | $3M |
| ALHCALIGNMENT HEALTHCARE INC | NEW | +130.0K | 130.0K | +$2M | $2M |
| LLYELI LILLY & CO | NEW | +2.7K | 2.7K | +$2M | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $222M | 137 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $260M | 125 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $281M | 122 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $265M | 119 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $247M | 118 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $295M | 115 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $291M | 109 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $275M | 109 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $313M | 112 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $312M | 128 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $293M | 136 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $314M | 135 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $310M | 129 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $353M | 129 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $350M | 127 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $361M | 130 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $530M | 140 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $563M | 138 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $699M | 146 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $725M | 147 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $695M | 164 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $599M | 138 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $535M | 148 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $591M | 142 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $522M | 152 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $793M | 139 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $667M | 147 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $700M | 150 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $708M | 145 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $608M | 139 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.